Cathie Wood: portfolio of ARK Investment Management
Cathie Wood leads ARK Investment Management, which offers actively managed funds focused on technology and innovation.
Source: 13F filing with the US Securities and Exchange Commission dated Aug 5, 2021. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q2 2021. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 53.7B USD
- Positions
- 285
- Share of the ten largest
- 35.8%
The ten largest positions Q2 2021
- Tesla, Inc. 6.9%▼ −6.1%
- Teladoc Health Inc 5.0%▲ +11.0%
- Roku Inc 4.1%▼ −5.1%
- Block, Inc. 3.6%▼ −26.8%
- Shopify 3.3%▲ +13.6%
- Twilio 2.7%▲ +36.0%
- Coinbase 2.6%new
- Zoom Video Communications Inc 2.6%▲ +22.2%
- Exact Sciences Corp 2.5%▲ +17.3%
- Spotify Technology SA 2.5%▲ +23.1%
Show all positions of this quarter
Choose a quarter (40 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
All positions Q2 2021
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| TSLA Tesla, Inc. | 6.9% | 5,433,702 | 3.7B USD | −6.1% reduced | Q4 2016 or earlier 19 quarters |
| Roku Inc | 4.1% | 4,741,612 | 2.2B USD | −5.1% reduced | Q2 2019 9 quarters |
| XYZ Block, Inc. | 3.6% | 8,039,354 | 2.0B USD | −26.8% reduced | Q4 2016 or earlier 19 quarters |
| CRISPR Therapeutics AG | 2.3% | 7,776,119 | 1.3B USD | −6.2% reduced | Q2 2017 17 quarters |
| Intellia Therapeutics Inc | 2.3% | 7,684,441 | 1.2B USD | −20.1% reduced | Q4 2016 or earlier 19 quarters |
| DocuSign Inc | 1.5% | 2,806,990 | 784.8M USD | −12.2% reduced | Q3 2019 8 quarters |
| SE Sea Limited (ADR) | 1.4% | 2,829,917 | 777.1M USD | −10.8% reduced | Q4 2019 7 quarters |
| Invitae Corp | 1.3% | 21,400,230 | 721.8M USD | −10.7% reduced | Q4 2016 or earlier 19 quarters |
| Pacific Biosciences of Califor | 1.3% | 20,481,486 | 716.2M USD | −3.8% reduced | Q3 2019 8 quarters |
| Twist Bioscience Corp | 1.3% | 5,054,864 | 673.6M USD | −16.4% reduced | Q2 2019 9 quarters |
| IOVA Iovance Biotherapeutics | 0.9% | 18,450,713 | 480.1M USD | −6.5% reduced | Q1 2018 14 quarters |
| Tencent Holdings Ltd | 0.8% | 6,003,916 | 452.1M USD | −12.6% reduced | Q3 2017 16 quarters |
| Editas Medicine Inc | 0.8% | 7,180,055 | 406.7M USD | −18.0% reduced | Q1 2017 18 quarters |
| REGN Regeneron Pharmaceuticals | 0.7% | 713,048 | 398.3M USD | −41.5% reduced | Q4 2020 3 quarters |
| 2U Inc | 0.7% | 9,382,118 | 391.0M USD | −20.7% reduced | Q4 2016 or earlier 19 quarters |
| Novartis AG | 0.7% | 4,274,698 | 389.5M USD | −40.8% reduced | Q4 2020 3 quarters |
| Nintendo Co Ltd | 0.7% | 5,234,196 | 379.6M USD | −16.3% reduced | Q3 2020 4 quarters |
| TER Teradyne | 0.7% | 2,784,316 | 373.0M USD | −3.2% reduced | Q4 2016 or earlier 19 quarters |
| PagerDuty Inc | 0.7% | 8,593,607 | 365.9M USD | −13.9% reduced | Q1 2020 6 quarters |
| P Everpure | 0.6% | 15,254,370 | 297.9M USD | −53.6% reduced | Q1 2020 6 quarters |
| PYPL PayPal | 0.5% | 965,633 | 281.5M USD | −42.5% reduced | Q4 2016 or earlier 19 quarters |
| Proto Labs Inc | 0.5% | 3,030,630 | 278.2M USD | −17.1% reduced | Q4 2016 or earlier 19 quarters |
| BEKE KE Holdings | 0.5% | 5,801,313 | 276.6M USD | −39.5% reduced | Q4 2020 3 quarters |
| Veracyte Inc | 0.5% | 6,689,263 | 267.4M USD | −12.2% reduced | Q4 2016 or earlier 19 quarters |
| Takeda Pharmaceutical Co Ltd | 0.5% | 15,492,997 | 260.7M USD | −17.2% reduced | Q3 2020 4 quarters |
| INCY Incyte | 0.5% | 2,948,967 | 248.1M USD | −1.3% reduced | Q4 2016 or earlier 19 quarters |
| Roche Holding AG | 0.4% | 5,002,547 | 235.1M USD | −38.3% reduced | Q4 2020 3 quarters |
| Seres Therapeutics Inc | 0.4% | 9,713,160 | 231.7M USD | −18.1% reduced | Q4 2016 or earlier 19 quarters |
| Stratasys Ltd | 0.4% | 8,872,166 | 229.4M USD | −14.9% reduced | Q4 2016 or earlier 19 quarters |
| NanoString Technologies Inc | 0.4% | 2,987,927 | 193.6M USD | −9.9% reduced | Q4 2016 or earlier 19 quarters |
| MELI MercadoLibre | 0.4% | 121,521 | 189.3M USD | −5.3% reduced | Q4 2016 or earlier 19 quarters |
| Castle Biosciences Inc | 0.3% | 2,525,613 | 185.2M USD | −2.8% reduced | Q3 2019 8 quarters |
| OPEN Opendoor Technologies | 0.3% | 10,139,232 | 179.8M USD | −12.9% reduced | Q4 2020 3 quarters |
| SNAP Snap | 0.3% | 2,214,665 | 150.9M USD | −30.2% reduced | Q3 2019 8 quarters |
| Materialise NV | 0.3% | 6,189,551 | 149.1M USD | −16.8% reduced | Q4 2016 or earlier 19 quarters |
| BIDU Baidu (ADR) | 0.3% | 680,236 | 138.7M USD | −86.7% reduced | Q4 2016 or earlier 19 quarters |
| Pinterest Inc | 0.2% | 1,655,743 | 130.7M USD | −46.5% reduced | Q3 2019 8 quarters |
| Adyen NV | 0.2% | 52,517 | 128.2M USD | −8.5% reduced | Q1 2019 10 quarters |
| LendingClub Corp | 0.2% | 7,055,731 | 127.9M USD | −2.9% reduced | Q2 2019 9 quarters |
| BMY Bristol Myers Squibb | 0.2% | 1,902,838 | 127.1M USD | −12.7% reduced | Q1 2021 2 quarters |
| Personalis Inc | 0.2% | 4,941,964 | 125.0M USD | −13.4% reduced | Q2 2019 9 quarters |
| Cerus Corp | 0.2% | 20,942,911 | 123.8M USD | −18.0% reduced | Q4 2016 or earlier 19 quarters |
| BABA Alibaba Group (ADR) | 0.2% | 462,651 | 104.9M USD | −21.7% reduced | Q4 2016 or earlier 19 quarters |
| ICE Intercontinental Exchange | 0.2% | 849,974 | 100.9M USD | −84.9% reduced | Q1 2018 14 quarters |
| META Meta Platforms | 0.2% | 289,387 | 100.6M USD | −5.7% reduced | Q2 2019 9 quarters |
| Compugen Ltd | 0.2% | 11,975,607 | 99.2M USD | −17.0% reduced | Q4 2016 or earlier 19 quarters |
| Arcturus Therapeutics Holdings | 0.2% | 2,884,682 | 97.6M USD | −13.4% reduced | Q2 2019 9 quarters |
| DE Deere & Company | 0.2% | 247,363 | 87.2M USD | −30.2% reduced | Q3 2017 16 quarters |
| Silvergate Capital Corp | 0.1% | 700,831 | 79.4M USD | −63.9% reduced | Q4 2019 7 quarters |
| ZhongAn Online P&C Insurance C | 0.1% | 13,844,663 | 78.3M USD | −26.9% reduced | Q1 2019 10 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 largest of 152 positions.
Breakdown by sector
- Technology 7.2%
- Financials 7.1%
- Consumer Discretionary 7.0%
- Health Care 3.7%
- Communication Services 0.9%
- Industrials 0.7%
- Real Estate 0.3%
- not in our coverage 73.0%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors